相似文献
1
Comparison between sequence analysis and a line probe assay for testing genotypic resistance of human immunodeficiency virus type 1 to antiretroviral drugs.用于检测人类免疫缺陷病毒1型对抗逆转录病毒药物基因型耐药性的序列分析与线性探针分析的比较。
J Clin Microbiol. 2005 Aug;43(8):4186-8. doi: 10.1128/JCM.43.8.4186-4188.2005.
2
Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy.对接受高效抗逆转录病毒治疗失败的患者，比较DNA测序和线性探针分析检测1型人类免疫缺陷病毒耐药突变的效果。
J Clin Microbiol. 2001 Feb;39(2):454-9. doi: 10.1128/JCM.39.2.454-459.2001.
3
4
HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.来自阿根廷的垂直感染患者的1型艾滋病毒基因型耐药谱揭示了K103N+L100I和L74V突变之间的关联。
Antivir Ther. 2010;15(4):641-50. doi: 10.3851/IMP1571.
5
Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.西班牙马德里未接受治疗和已接受治疗的 HIV-1 感染儿科人群中的耐药流行率和 HIV-1 变异特征。
J Antimicrob Chemother. 2011 Oct;66(10):2362-71. doi: 10.1093/jac/dkr305. Epub 2011 Aug 2.
6
RNA extraction prior to HIV-1 resistance detection using Line Probe Assay (LiPA): comparison of three methods.使用线性探针分析（LiPA）进行HIV-1耐药性检测之前的RNA提取：三种方法的比较。
J Clin Virol. 2005 Apr;32(4):265-71. doi: 10.1016/j.jcv.2004.08.007.
7
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.人类免疫缺陷病毒基因耐药性检测对治疗效果的影响研究。
Verh K Acad Geneeskd Belg. 2001;63(5):447-73.
8
Antiretroviral resistance mutations among pregnant human immunodeficiency virus type 1-infected women and their newborns in the United States: vertical transmission and clades.美国感染人类免疫缺陷病毒1型的孕妇及其新生儿中的抗逆转录病毒耐药性突变：垂直传播与进化枝
J Infect Dis. 2001 Nov 1;184(9):1120-6. doi: 10.1086/323804. Epub 2001 Sep 20.
9
Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium.比利时未接受过抗逆转录病毒治疗的HIV-1感染患者中基因型耐药的流行情况。
Antivir Ther. 2001 Mar;6(1):63-70.
10
HIV-1 drug resistance in variants from the female genital tract and plasma.来自女性生殖道和血浆的变异体中的HIV-1耐药性。
J Infect Dis. 2007 Feb 15;195(4):535-45. doi: 10.1086/510855. Epub 2007 Jan 8.
引用本文的文献
1
Restriction fragment mass polymorphism (RFMP) analysis based on MALDI-TOF mass spectrometry for detecting antiretroviral resistance in HIV-1 infected patients.基于 MALDI-TOF 质谱的限制性片段质量多态性 (RFMP) 分析用于检测 HIV-1 感染患者的抗逆转录病毒耐药性。
Clin Microbiol Infect. 2013 Jun;19(6):E263-70. doi: 10.1111/1469-0691.12167. Epub 2013 Mar 11.
2
Sensitive oligonucleotide ligation assay for low-level detection of nevirapine resistance mutations in human immunodeficiency virus type 1 quasispecies.用于低水平检测1型人类免疫缺陷病毒准种中奈韦拉平耐药性突变的灵敏寡核苷酸连接测定法。
J Clin Microbiol. 2007 Aug;45(8):2604-15. doi: 10.1128/JCM.00431-07. Epub 2007 Jun 13.
本文引用的文献
1
Performance of the VERSANT HIV-1 resistance assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes.VERSANT HIV-1耐药性检测（线性探针分析）在检测初治的感染不同HIV-1亚型患者耐药性方面的表现。
FEMS Immunol Med Microbiol. 2003 Nov 28;39(2):119-24. doi: 10.1016/S0928-8244(03)00240-2.
2
Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.1型人类免疫缺陷病毒感染成人的抗逆转录病毒药物耐药性检测：美国国际艾滋病学会专家组2003年建议
Clin Infect Dis. 2003 Jul 1;37(1):113-28. doi: 10.1086/375597. Epub 2003 Jun 23.
3
Evaluation of the LiPA HIV-1 RT assay version 1: comparison of sequence and hybridization based genotyping systems.LiPA HIV-1 RT检测法第1版的评估：基于序列和杂交的基因分型系统的比较
J Clin Virol. 2002 Dec;25 Suppl 3:S65-72. doi: 10.1016/s1386-6532(02)00190-7.
4
Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting. The EuroGUidelines Group for HIV resistance.作为治疗管理一部分的HIV-1耐药性检测使用的临床和实验室指南：欧洲背景下的建议。欧洲HIV耐药性指南小组
AIDS. 2001 Feb 16;15(3):309-20. doi: 10.1097/00002030-200102160-00003.
5
Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy.对接受高效抗逆转录病毒治疗失败的患者，比较DNA测序和线性探针分析检测1型人类免疫缺陷病毒耐药突变的效果。
J Clin Microbiol. 2001 Feb;39(2):454-9. doi: 10.1128/JCM.39.2.454-459.2001.
6
A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215.对接受齐多夫定与拉米夫定、去羟肌苷或扎西他滨联合治疗的患者进行基因型分析，采用线性探针分析（LiPA）点突变检测法检测第41、69、70、74、184和215密码子处的基因型变异。
J Clin Virol. 2000 Dec;19(3):135-42. doi: 10.1016/s1386-6532(00)00087-1.
7
Substantial correlation between HIV type 1 drug-associated resistance mutations in plasma and peripheral blood mononuclear cells in treatment-experienced patients.在有治疗经验的患者中，血浆和外周血单个核细胞中1型人类免疫缺陷病毒（HIV-1）与药物相关的耐药性突变之间存在显著相关性。
AIDS Res Hum Retroviruses. 2000 Jul 20;16(11):1025-30. doi: 10.1089/08892220050075273.
8
Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations.对于检测混合HIV-1基因型群体中的耐药性，表型检测和测序比点突变检测的敏感性更低。
J Acquir Immune Defic Syndr. 1999 Oct 1;22(2):107-18. doi: 10.1097/00126334-199910010-00001.
9
10
Human immunodeficiency virus type 1 cloning vectors for antiretroviral resistance testing.用于抗逆转录病毒耐药性检测的1型人类免疫缺陷病毒克隆载体。
J Clin Microbiol. 1999 Sep;37(9):2943-51. doi: 10.1128/JCM.37.9.2943-2951.1999.
Zotero 插件